GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3

Recent financial changes

Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.

Search securities →
AIC3.ai, Inc.
MEDIUM IMPORTANCER And D100TH HISTORICAL PCTL

Research & development decreased 28.0%

Research & development changed -28.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.

$64.7M$46.5M2 prior comparisons
MEDIUM IMPORTANCER And DR And D Acceleration100TH HISTORICAL PCTL

Research & development changed across a low base

Research & development changed +4044.4% from the comparable as-filed period. The change ranks at the 100th percentile of 5 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.

$9,000$373,0005 prior comparisons
GNLXGENELUX Corp
MEDIUM IMPORTANCER And DR And D Acceleration50TH HISTORICAL PCTL

Research & development increased 36.8%

Research & development changed +36.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.

$4.8M$6.5M4 prior comparisons
CRMDCorMedix Inc.
MEDIUM IMPORTANCER And DR And D Acceleration75TH HISTORICAL PCTL

Research & development increased 173.6%

Research & development changed +173.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.

$2.4M$6.7M4 prior comparisons
MEDIUM IMPORTANCER And DR And D Acceleration100TH HISTORICAL PCTL

Research & development changed across a low base

Research & development changed +1020.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.

$116,383$1.3M4 prior comparisons
SNALSnail, Inc.
MEDIUM IMPORTANCER And DR And D Acceleration50TH HISTORICAL PCTL

Research & development increased 35.2%

Research & development changed +35.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.

$3.3M$4.5M4 prior comparisons
ARQArq, Inc.
MEDIUM IMPORTANCER And D67TH HISTORICAL PCTL

Research & development decreased 64.5%

Research & development changed -64.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.

$2.7M$958,0003 prior comparisons

Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.